Latest Capital Raises News

Pinnacle West has extended its 8%-10% annual sales growth outlook through 2030 as manufacturing, data centres and residential expansion reshape Arizona’s electricity demand. The plan points to a large investment cycle, but also greater financing and regulatory execution demands.

Tetragon Energy has lodged a prospectus for up to 9.93 million free options that could generate $11.91 million if fully exercised. The offer raises no money upfront, leaves the options unquoted and adds a speculative funding path to the company’s Philippine oil and gas strategy.

Starpharma is targeting a December start for first-in-human testing of its lead DEP HER2-Lu radiopharmaceutical, subject to ethics approval, as it shifts decisively toward targeted oncology. The company also outlined stronger funding, majority ownership of Petalion’s FAP program and a proposed Chair transition at its 2026 AGM.

ADX Energy has begun an eight-week Austrian well work program targeting up to 115 BOEPD of incremental oil and gas production, while preparing HOCH-1 for deeper gas testing. The work spans two Vienna Basin completions, a pump replacement and a test of Hall Channel reservoirs with potential for broader lateral extension.

Riversgold has locked in $1.55 million from sophisticated and professional investors to fund its E25/594 acquisition from Black Cat Syndicate. The deal would expand the Kalgoorlie-Northern Zone Project nearly 15-fold, but more than 258 million new shares will be issued across two tranches.

Avenira has raised $48.87 million through its rights issue and shortfall placement, with major shareholder Hebang among those taking up entitlements. Combined with $85 million of debt facilities, the company expects the funding to cover the direct shipping ore phase at Wonarah ahead of planned first shipment in the first half of 2027.

Count has completed a fully underwritten $25.0 million institutional placement to help fund its planned acquisition of a 75% interest in Skybridge Financial Group. The acquisition still requires ACCC clearance or a notification waiver before completion, targeted for Q3 FY2027.

Macquarie Group delivered a 50% rise in first-half profit to A$2.478 billion, with Commodities and Global Markets providing the standout contribution as market activity accelerated. The result also marks Shemara Wikramanayake’s final day as chief executive, with Greg Ward taking over from 7 November.

AVITA Medical has raised its 2026 revenue guidance for a second time after third-quarter revenue climbed 53% year on year. The company also drew a further US$10 million under its credit facility and removed its going-concern qualification, although it remains loss-making and highly leveraged.

Gryphon Capital Income Trust will give eligible Australian and New Zealand unitholders the chance to buy up to A$30,000 of new units at A$2.00 each. The non-underwritten offer could raise up to A$407.45 million for incremental portfolio management.

AXP Energy received applications for $262,214 in its 1-for-1 entitlement offer, far below the $1.2 million minimum subscription. A separate shortfall offer remains open until 3 February 2027, leaving the final capital raised unresolved.

Pathkey.AI has presented Chipforge as a functioning end-to-end AI platform for chip design, backed by independent testing, benchmark comparisons and a first proof-of-value contract. The harder test now is converting that engineering progress into recurring revenue before its A$5.8 million cash balance becomes a constraint.